Jump to content

Talk:Discovery and development of triptans

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 17:43, 23 October 2016 (Merge 5-HT1D receptor agonist: done). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
WikiProject iconPharmacology C‑class Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
CThis article has been rated as C-class on Wikipedia's content assessment scale.
MidThis article has been rated as Mid-importance on the project's importance scale.

Merge?

A merge with the Triptan article may be a good idea. We don't need two separate articles. --PFHLai (talk) 15:38, 17 November 2008 (UTC)[reply]

Pls see WT:PHARM#University project?. --PFHLai (talk)
Since the discussion is now archived, here's a direct link to the WT:PHARM#University project? discussion -> http://en.wikipedia.org/wiki/Wikipedia_talk:WikiProject_Pharmacology/Archive_2#University_project.3F - Ageekgal (talk) 21:43, 8 September 2009 (UTC)[reply]

FIG2

Figure 2 seems empty (FireFox 3.0 for Linux) 77.125.210.44 (talk) 14:09, 12 July 2009 (UTC)[reply]

I boldly merged most of 5-HT1D receptor agonist into Triptan, but the rest should probably go here. Thoughts? --ἀνυπόδητος (talk) 15:46, 29 September 2016 (UTC)[reply]

 Done --ἀνυπόδητος (talk) 17:43, 23 October 2016 (UTC)[reply]